This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order with a ceiling value of $2,172.95 and a completion date of March 21, 2025. The contract is not designated as a set-aside....
This contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,051,048 units of the pharmaceutical product glycopyrrolate 1ML 25S. The contract has a ceiling value of $3,368.70 and is a firm fixed-price delivery order. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,910.85 firm fixed-price contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML medication, a critical pharmaceutical product used in medical treatment. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, SPE2DB20D7059|SPE2DB25FPWL4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,495.04 fixed-price delivery order is for the supply of 4,566,696,580 units of the medication Glycopyrrolate 1 mg/5 ml vial. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,442.46, is for the supply of GLYCOPYRROLATE INJECT, a medication, and is a firm fixed-price delivery order with an ultimate completion date of August 15, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of glycopyrrolate 1 mg/5 ml vials. The contract has a ceiling value of $1,867.08 and a period of performance through December 9, 2024. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,950.54, is for the delivery of 4565120442 - GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. This award is a delivery order under a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vials (2 ml) to support military healthcare programs. The contract is a firm fixed-price, delivery order with a ceiling value of $7,599.65 and a period of performance through March 4, 2024. The award is not designated as a set-aside contract. In...